ストックスクリーナーアプリを入手
8.20
2.12%
0.17
プレマーケット:
8.32
0.12
+1.46%
Cogent Biosciences Inc (COGT) 最新ニュース
Assenagon Asset Management S.A. Sells 133,515 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent and ModivCare gain after insider purchases - MSN
How to Take Advantage of moves in (COGT) - Stock Traders Daily
Short Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Expands By 9.3% - MarketBeat
Cogent Biosciences Appoints James P. Geygan as Independent Director - Defense World
Hennion & Walsh Asset Management Inc. Buys 103,293 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data - Seeking Alpha
This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - Yahoo Finance
Cole Pinnow Bought 2,085% More Shares In Cogent Biosciences - Yahoo Finance
HC Wainwright Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $14.00 - Defense World
Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Price Target at $14.83 - Defense World
Cogent Biosciences chief commercial officer buys $332,412 in stock By Investing.com - Investing.com Canada
Cogent stock ModivCare stock up on insider buys (COGT:NASDAQ) - Seeking Alpha
Cogent Biosciences (NASDAQ:COGT) Shares Gap UpHere's What Happened - MarketBeat
Cogent Biosciences chief commercial officer buys $332,412 in stock - Investing.com
HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.83 Average Target Price from Analysts - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Receives Neutral Rating from Wedbush - Defense World
Wedbush Reiterates Neutral Rating for Cogent Biosciences (NASDAQ:COGT) - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Trading Down 11.9%Here's Why - MarketBeat
Cogent Biosciences Announces Planned 2025 Milestones for - GlobeNewswire
Cogent Biosciences sets key 2025 milestones for drug trials By Investing.com - Investing.com South Africa
Cogent Biosciences sets key 2025 milestones for drug trials - Investing.com India
Cogent Biosciences Sets Major 2025 Milestones: Three Phase 3 Results, First NDA Submission Planned - StockTitan
Objective long/short (COGT) Report - Stock Traders Daily
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Cogent Biosciences CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Cogent Biosciences (NASDAQ:COGT) Shares Up 8.8%Still a Buy? - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Trading Down 2.5%What's Next? - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Holdings Trimmed by Jane Street Group LLC - Defense World
Jane Street Group LLC Reduces Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
(COGT) Investment Report - Stock Traders Daily
Geode Capital Management LLC Buys 300,062 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Geode Capital Management LLC Purchases 300,062 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Barclays PLC Boosts Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Barclays PLC Has $1.90 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.83 Consensus Target Price from Analysts - Defense World
State Street Corp Sells 605,500 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Cogent Biosciences (NASDAQ:COGT) Trading Down 4.4%What's Next? - MarketBeat
Here's Why We're Watching Cogent Biosciences' (NASDAQ:COGT) Cash Burn Situation - Simply Wall St
Cogent Biosciences, Inc. (NASDAQ:COGT) Stake Lowered by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Why Is Cogent Biosciences Stock Trading Higher On Monday? - AOL
Cogent Biosciences, Inc. (NASDAQ:COGT) Sees Large Increase in Short Interest - MarketBeat
What is HC Wainwright’s Forecast for COGT FY2024 Earnings? - Defense World
HC Wainwright Issues Pessimistic Estimate for COGT Earnings - MarketBeat
Needham Downgrades Cogent Biosciences (COGT) - MSN
Cogent Biosciences (NASDAQ:COGT) Receives "Buy" Rating from HC Wainwright - MarketBeat
Needham & Company LLC Downgrades Cogent Biosciences (NASDAQ:COGT) to Hold - MarketBeat
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by Charles Schwab Investment Management Inc. - MarketBeat
Charles Schwab Investment Management Inc. Has $8.92 Million Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
4.81%
大文字化:
|
ボリューム (24 時間):